Jim Young
The comparative effectiveness of NRTI-sparing dual regimens in emulated trials using observational data from the Swiss HIV Cohort Study
Young J, Bucher H, Günthard H, Vernazza P, Hachfeld A, Cavassini M, Bernasconi E, Tarr P, Calmy A, Scherrer A, Swiss HIV Cohort Study. The comparative effectiveness of NRTI-sparing dual regimens in emulated trials using observational data from the Swiss HIV Cohort Study. Antivir Ther (Lond) 2019
Apr 15, 2019The comparative effectiveness of NRTI-sparing dual regimens in emulated trials using observational data from the Swiss HIV Cohort Study
Apr 15, 2019Antivir Ther (Lond) 2019
Young Jim, Bucher Heiner C, Günthard Huldrych F, Vernazza Pietro, Hachfeld Anna, Cavassini Matthias, Bernasconi Enos, Tarr Philip E, Calmy Alexandra, Scherrer Alexandra U, Swiss HIV Cohort Study
Factors associated with syphilis incidence in the HIV-infected in the era of highly active antiretrovirals
Shilaih M, Kouyos R, Günthard H, Thurnheer M, Bernasconi E, Hoffmann M, Battegay M, Darling K, Calmy A, Young J, Kovari H, Scherrer A, Braun D, Marzel A. Factors associated with syphilis incidence in the HIV-infected in the era of highly active antiretrovirals. Medicine (Baltimore) 2017; 96:e5849.
Jan 1, 2017Factors associated with syphilis incidence in the HIV-infected in the era of highly active antiretrovirals
Jan 1, 2017Medicine (Baltimore) 2017; 96:e5849
Shilaih Mohaned, Kouyos Roger D, Günthard Huldrych F, Thurnheer Maria C, Bernasconi Enos, Hoffmann Matthias, Battegay Manuel, Darling Katharine, Calmy Alexandra, Young Jim, Kovari Helen, Scherrer Alexandra U, Braun Dominique L, Marzel Alex
Transient detectable viremia and the risk of viral rebound in patients from the Swiss HIV Cohort Study
Young J, Bucher H, Günthard H, Battegay M, Cavassini M, Schmid P, Staehelin C, Bernasconi E, Calmy A, Rickenbach M, Swiss HIV Cohort Study. Transient detectable viremia and the risk of viral rebound in patients from the Swiss HIV Cohort Study. BMC Infect Dis 2015; 15:382.
Sep 21, 2015Transient detectable viremia and the risk of viral rebound in patients from the Swiss HIV Cohort Study
Sep 21, 2015BMC Infect Dis 2015; 15:382
Young Jim, Bucher Heiner C, Günthard Huldrych F, Battegay Manuel, Cavassini Matthias, Schmid Patrick, Staehelin Cornelia, Bernasconi Enos, Calmy Alexandra, Rickenbach Martin, Swiss HIV Cohort Study
Effect of Cumulating Exposure to Abacavir on the Risk of Cardiovascular Disease Events in Patients From the Swiss HIV Cohort Study
Young J, Bucher H, Weber R, Cusini A, Cavassini M, Calmy A, Schmid P, Bernasconi E, Klein M, Abrahamowicz M, Moodie E, Xiao Y, Swiss HIV Cohort Study. Effect of Cumulating Exposure to Abacavir on the Risk of Cardiovascular Disease Events in Patients From the Swiss HIV Cohort Study. J Acquir Immune Defic Syndr 2015; 69:413-21.
Aug 1, 2015Effect of Cumulating Exposure to Abacavir on the Risk of Cardiovascular Disease Events in Patients From the Swiss HIV Cohort Study
Aug 1, 2015J Acquir Immune Defic Syndr 2015; 69:413-21
Young Jim, Bucher Heiner C, Weber Rainer, Cusini Alexia, Cavassini Matthias, Calmy Alexandra, Schmid Patrick, Bernasconi Enos, Klein Marina B, Abrahamowicz Michal, Moodie Erica E M, Xiao Yongling, Swiss HIV Cohort Study
Virologic and immunologic responses in treatment-naive patients to ritonavir-boosted atazanavir or efavirenz with a common backbone
Wang Q, Battegay M, Bucher H, Fehr J, Furrer H, Cavassini M, Calmy A, Vernazza P, Bernasconi E, Young J, Swiss HIV Cohort Study. Virologic and immunologic responses in treatment-naive patients to ritonavir-boosted atazanavir or efavirenz with a common backbone. HIV Clin Trials 2014; 15:92-103.
May 1, 2014Virologic and immunologic responses in treatment-naive patients to ritonavir-boosted atazanavir or efavirenz with a common backbone
May 1, 2014HIV Clin Trials 2014; 15:92-103
Wang Qing, Battegay Manuel, Bucher Heiner C, Fehr Jan, Furrer Hansjakob, Cavassini Matthias, Calmy Alexandra, Vernazza Pietro, Bernasconi Enos, Young Jim, Swiss HIV Cohort Study
The prevalence of erectile dysfunction and its association with antiretroviral therapy in HIV-infected men: the Swiss HIV Cohort Study
Wang Q, Fux C, Bucher H, Stoeckle M, Furrer H, Weber R, Hirschel B, Vernazza P, Cavassini M, Bernasconi E, Young J, Swiss HIV Cohort Study. The prevalence of erectile dysfunction and its association with antiretroviral therapy in HIV-infected men: the Swiss HIV Cohort Study. Antivir Ther (Lond) 2012; 18:337-44.
Sep 12, 2012The prevalence of erectile dysfunction and its association with antiretroviral therapy in HIV-infected men: the Swiss HIV Cohort Study
Sep 12, 2012Antivir Ther (Lond) 2012; 18:337-44
Wang Qing, Fux Christoph, Bucher Heiner C, Stoeckle Marcel, Furrer Hansjakob, Weber Rainer, Hirschel Bernard, Vernazza Pietro, Cavassini Matthias, Bernasconi Enos, Young Jim, Swiss HIV Cohort Study
Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir
Young J, Bucher H, Battegay M, Weber R, Cavassini M, Calmy A, Vernazza P, Bernasconi E, Furrer H, Fux C, Schäfer J, the Swiss HIV Cohort Study. Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir. AIDS 2012; 26:567-575.
Mar 13, 2012Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir
Mar 13, 2012AIDS 2012; 26:567-575
Young Jim, Bucher Heiner C, Battegay Manuel, Weber Rainer, Cavassini Matthias, Calmy Alexandra, Vernazza Pietro, Bernasconi Enos, Furrer Hansjakob, Fux Christoph A, Schäfer Juliane, the Swiss HIV Cohort Study
Randomized trial of a computerized coronary heart disease risk assessment tool in HIV-infected patients receiving combination antiretroviral therapy
Bucher H, Battegay M, Weber R, Vernazza P, Schiffer V, Fux C, Cavassini M, Bernasconi E, Vallet Y, Glass T, Young J, Rickenbach M, the Swiss HIV Cohort Study. Randomized trial of a computerized coronary heart disease risk assessment tool in HIV-infected patients receiving combination antiretroviral therapy. Antivir Ther 2010; 15:31-40.
Jan 1, 2010Randomized trial of a computerized coronary heart disease risk assessment tool in HIV-infected patients receiving combination antiretroviral therapy
Jan 1, 2010Antivir Ther 2010; 15:31-40
Bucher Heiner C, Battegay Manuel, Weber Rainer, Vernazza Pietro, Schiffer Véronique, Fux Christoph, Cavassini Matthias, Bernasconi Enos, Vallet Yannick, Glass Tracy R, Young Jim, Rickenbach Martin, the Swiss HIV Cohort Study
Hierarchical modeling gave plausible estimates of associations between metabolic syndrome and components of antiretroviral therapy
Young J, Bucher H, Battegay M, Vernazza P, Tarr P, Hirschel B, Furrer H, Rickenbach M, Bernasconi E, Glass T, Swiss HIV Cohort Study. Hierarchical modeling gave plausible estimates of associations between metabolic syndrome and components of antiretroviral therapy. Journal of clinical epidemiology 2009; 62:632-41.
Jun 1, 2009Hierarchical modeling gave plausible estimates of associations between metabolic syndrome and components of antiretroviral therapy
Jun 1, 2009Journal of clinical epidemiology 2009; 62:632-41
Young Jim, Bucher Heiner C, Battegay Manuel, Vernazza Pietro, Tarr Philip E, Hirschel Bernard, Furrer Hansjakob, Rickenbach Martin, Bernasconi Enos, Glass Tracy R, Swiss HIV Cohort Study
Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIV
Young J, Battegay M, Bernasconi E, Vernazza P, Cavassini M, Hirschel B, Fux C, Rickenbach M, Guenthard H, Bucher H, Swiss HIV Cohort Study. Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIV. Antiviral therapy 2009; 14:771-9.
Jan 1, 2009Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIV
Jan 1, 2009Antiviral therapy 2009; 14:771-9
Young Jim, Battegay Manuel, Bernasconi Enos, Vernazza Pietro, Cavassini Matthias, Hirschel Bernard, Fux Christoph A, Rickenbach Martin, Guenthard Huldrych F, Bucher Heiner C, Swiss HIV Cohort Study
Body fat changes among antiretroviral-naive patients on PI- and NNRTI-based HAART in the Swiss HIV cohort study
Young J, Battegay M, Vernazza P, Tarr P, Hirschel B, Bernasconi E, Furrer H, Weber R, Rickenbach M, Bucher H. Body fat changes among antiretroviral-naive patients on PI- and NNRTI-based HAART in the Swiss HIV cohort study. Antiviral therapy 2005; 10:73-81.
Jan 1, 2005Body fat changes among antiretroviral-naive patients on PI- and NNRTI-based HAART in the Swiss HIV cohort study
Jan 1, 2005Antiviral therapy 2005; 10:73-81
Young Jim, Battegay Manuel, Vernazza Pietro, Tarr Philip E, Hirschel Bernard, Bernasconi Enos, Furrer Hansjakob, Weber Rainer, Rickenbach Martin, Bucher Heiner C
Lipid profiles for antiretroviral-naive patients starting PI- and NNRTI-based therapy in the Swiss HIV cohort study
Young J, Battegay M, Vernazza P, Tarr P, Hirschel B, Bernasconi E, Furrer H, Rickenbach M, Weber R, Bucher H. Lipid profiles for antiretroviral-naive patients starting PI- and NNRTI-based therapy in the Swiss HIV cohort study. Antiviral therapy 2005; 10:585-91.
Jan 1, 2005Lipid profiles for antiretroviral-naive patients starting PI- and NNRTI-based therapy in the Swiss HIV cohort study
Jan 1, 2005Antiviral therapy 2005; 10:585-91
Young Jim, Battegay Manuel, Vernazza Pietro, Tarr Philip E, Hirschel Bernard, Bernasconi Enos, Furrer Hansjakob, Rickenbach Martin, Weber Rainer, Bucher Heiner C
Is unsafe sexual behaviour increasing among HIV-infected individuals?
Glass T, Bucher H, Battegay M, Hirschel B, Cavassini M, Weber R, Rickenbach M, Vernazza P, Young J, Swiss HIV Cohort Study. Is unsafe sexual behaviour increasing among HIV-infected individuals?. AIDS (London, England) 2004; 18:1707-14.
Aug 20, 2004Is unsafe sexual behaviour increasing among HIV-infected individuals?
Aug 20, 2004AIDS (London, England) 2004; 18:1707-14
Glass Tracy R, Bucher Heiner C, Battegay Manuel, Hirschel Bernard, Cavassini Matthias, Weber Rainer, Rickenbach Martin, Vernazza Pietro, Young Jim, Swiss HIV Cohort Study
Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort study
Young J, Bucher H, Battegay M, Vernazza P, Telenti A, Hirschel B, Bernasconi E, Furrer H, Rickenbach M, Flepp M, Spirig R, De Geest S, Swiss HIV Cohort Study Group. Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort study. BMJ (Clinical research ed.) 2004; 328:15.
Jan 3, 2004Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort study
Jan 3, 2004BMJ (Clinical research ed.) 2004; 328:15
Young Jim, Bucher Heiner C, Battegay Manuel, Vernazza Pietro, Telenti Amalio, Hirschel Bernard, Bernasconi Enos, Furrer Hansjakob, Rickenbach Martin, Flepp Markus, Spirig Rebecca, De Geest Sabina, Swiss HIV Cohort Study Group